Iron Horse Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Iron Horse Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$9.35K	Sell	21 -1	-5%	-$461	﹤0.01%	298
2025 Q1	$10.7K	Buy	22 +1	+5%	+$466	﹤0.01%	262
2024 Q4	$8.46K	Hold	21	–	–	﹤0.01%	256
2024 Q3	$9.77K	Buy	21 +10	+91%	+$4.8K	﹤0.01%	240
2024 Q2	$5.16K	Hold	11	–	–	﹤0.01%	269
2024 Q1	$4.6K	Hold	11	–	–	﹤0.01%	264
2023 Q4	$4.48K	Hold	11	–	–	﹤0.01%	277
2023 Q3	$3.83K	Buy	+11	New	+$3.85K	﹤0.01%	292

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Iron Horse Wealth Management's VRTX Position: Q2 2025 in Review

Iron Horse Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 4.5% in Q2 2025, selling an estimated $461 and leaving 21 shares worth $9.35K. The position accounts for ﹤0.01% of the portfolio, ranked #298.

Iron Horse Wealth Management first reported a position in VRTX in Q3 2023 and has held it in 8 quarters since. The position peaked at $10.7K in Q1 2025. 1,563 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

Iron Horse Wealth Management held 21 shares of Vertex Pharmaceuticals worth $9.35K as of Q2 2025.
Iron Horse Wealth Management sold 1 Vertex Pharmaceuticals share in Q2 2025, an estimated $461.
Vertex Pharmaceuticals made up ﹤0.01% of Iron Horse Wealth Management's portfolio in Q2 2025, its #298 holding.
Iron Horse Wealth Management first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
Iron Horse Wealth Management's Vertex Pharmaceuticals position peaked at $10.7K in Q1 2025.
1,563 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.